Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01326871
Title A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Altor Bioscience Corporation, National Cancer Institute (NCI)
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Arizona Cancer Center Tucson Arizona 85724 United States Details
UF Health Center at Orlando Health Orlando Florida 32806 United States Details
Martin Health System Stuart Florida 34994 United States Details
H. Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Emory University Atlanta Georgia 30322 United States Details
Robert Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
University of Iowa Hospitals and Clinics Iowa City Iowa 52242 United States Details
University of Kansas Cancer Center Fairway Kansas 66205 United States Details
Karmanos Cancer Center Detroit Michigan 48201 United States Details
University of Minnesota Minneapolis Minnesota 55455 United States Details
Washington University St. Louis Missouri 63110 United States Details
Levine Cancer Institute Charlotte North Carolina 28203 United States Details
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104 United States Details
St. Luke's Hospital and Health Network Easton Pennsylvania 18045 United States Details
Thomas Jefferson University Hospital Philadelphia Pennsylvania 19107 United States Details
UPMC Cancer Center Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field